Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism

Part of paid clinical trials in Basking Ridge, New Jersey.

Sponsor
Memorial Sloan Kettering Cancer Center
Study ID
NCT07399977
Status
Recruiting
Apply to this trial

Conditions

  • Deep Venous Thrombosis
  • Venous Thromboembolism

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • MSK-ACCESS — DIAGNOSTIC_TEST
    MSK-ACCESS is a ctDNA sequencing assay
  • ctDNA/VTE Risk Score: — DIAGNOSTIC_TEST
    Machine learning Venous Thromboembolism/VTE risk score mode

Study Details

The purpose of this study is to find out whether a software tool, ctDNA/VTE (Venous Thromboembolism) risk score model, is an effective way to predict the likelihood of VTE coming back in people who have received anticoagulant treatment.

Key Dates

Start date
Jan 30, 2026
Status verified
May 2026
Primary completion
Jan 30, 2030
Completion
Jan 30, 2030

Study Design

Enrollment
259 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC

Arms

  • Experimental: High risk for recurrent Venous Thromboembolism/VTE
    Participants with a ≤5% chance of Venous Thromboembolism/VTE according to the model will be designated "low risk" for the purposes of the study; all other participants will be considered "high risk.
  • Experimental: Low-risk for recurrent Venous Thromboembolism/VTE
    Participants with a ≤5% chance of Venous Thromboembolism/VTE according to the model will be designated "low risk" for the purposes of the study; all other participants will be considered "high risk.

Primary Outcome Measure

Cumulative incidence of recurrent Venous Thromboembolism/VTE [ Time Frame: 6 months ]

Central Contacts

Locations (7)

FacilityCityStateZIPSite coordinators
Memorial Sloan Kettering Cancer Center Basking Ridge (All Protocol Activities)Basking RidgeNew Jersey07920
Justin Jee, MD, PhD
646-608-4409
Memorial Sloan Kettering Monmouth (All Protocol Activities)MiddletownNew Jersey07748
Justin Jee, MD, PhD
646-608-4409
Memorial Sloan Kettering Bergen (All Protocol Activities)MontvaleNew Jersey07645
Justin Jee, MD, PhD
646-608-4409
Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities)CommackNew York11725
Justin Jee, MD, PhD
646-608-4409
Memorial Sloan Kettering Westchester (All Protocol Activities)HarrisonNew York10604
Justin Jee, MD, PhD
646-608-4409
Memorial Sloan Kettering Cancer Center (All Protocol Activites)New YorkNew York10065
Justin Jee, MD, PhD
646-608-4409
Memorial Sloan Kettering Nassau (All protocol activities)Rockville CentreNew York11553
Justin Jee, MD, PhD
646-608-4409

Find similar trials in Basking Ridge, NJ

By research site
Memorial Sloan Kettering Cancer Center Basking Ridge (All Protocol Activities)· Basking Ridge, NJMemorial Sloan Kettering Monmouth (All Protocol Activities)· Middletown, NJMemorial Sloan Kettering Bergen (All Protocol Activities)· Montvale, NJMemorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities)· Commack, NYMemorial Sloan Kettering Westchester (All Protocol Activities)· Harrison, NYMemorial Sloan Kettering Cancer Center (All Protocol Activites)· New York, NY

Related Studies